165 related articles for article (PubMed ID: 17621263)
1. Ski can negatively regulates macrophage differentiation through its interaction with PU.1.
Ueki N; Zhang L; Hayman MJ
Oncogene; 2008 Jan; 27(3):300-7. PubMed ID: 17621263
[TBL] [Abstract][Full Text] [Related]
2. Ski negatively regulates erythroid differentiation through its interaction with GATA1.
Ueki N; Zhang L; Hayman MJ
Mol Cell Biol; 2004 Dec; 24(23):10118-25. PubMed ID: 15542823
[TBL] [Abstract][Full Text] [Related]
3. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors.
DeKoter RP; Walsh JC; Singh H
EMBO J; 1998 Aug; 17(15):4456-68. PubMed ID: 9687512
[TBL] [Abstract][Full Text] [Related]
4. PU.1 and the granulocyte- and macrophage colony-stimulating factor receptors play distinct roles in late-stage myeloid cell differentiation.
Anderson KL; Smith KA; Perkin H; Hermanson G; Anderson CG; Jolly DJ; Maki RA; Torbett BE
Blood; 1999 Oct; 94(7):2310-8. PubMed ID: 10498603
[TBL] [Abstract][Full Text] [Related]
5. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells.
Rekhtman N; Radparvar F; Evans T; Skoultchi AI
Genes Dev; 1999 Jun; 13(11):1398-411. PubMed ID: 10364157
[TBL] [Abstract][Full Text] [Related]
6. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor.
Dahl R; Walsh JC; Lancki D; Laslo P; Iyer SR; Singh H; Simon MC
Nat Immunol; 2003 Oct; 4(10):1029-36. PubMed ID: 12958595
[TBL] [Abstract][Full Text] [Related]
7. The transcriptional repressor GFI-1 antagonizes PU.1 activity through protein-protein interaction.
Dahl R; Iyer SR; Owens KS; Cuylear DD; Simon MC
J Biol Chem; 2007 Mar; 282(9):6473-83. PubMed ID: 17197705
[TBL] [Abstract][Full Text] [Related]
8. Stem cell fate specification: role of master regulatory switch transcription factor PU.1 in differential hematopoiesis.
Gangenahalli GU; Gupta P; Saluja D; Verma YK; Kishore V; Chandra R; Sharma RK; Ravindranath T
Stem Cells Dev; 2005 Apr; 14(2):140-52. PubMed ID: 15910240
[TBL] [Abstract][Full Text] [Related]
9. E2A Antagonizes PU.1 Activity through Inhibition of DNA Binding.
Rogers JH; Owens KS; Kurkewich J; Klopfenstein N; Iyer SR; Simon MC; Dahl R
Biomed Res Int; 2016; 2016():3983686. PubMed ID: 26942192
[TBL] [Abstract][Full Text] [Related]
10. GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia.
Burda P; Vargova J; Curik N; Salek C; Papadopoulos GL; Strouboulis J; Stopka T
PLoS One; 2016; 11(3):e0152234. PubMed ID: 27010793
[TBL] [Abstract][Full Text] [Related]
11. Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate.
Bakri Y; Sarrazin S; Mayer UP; Tillmanns S; Nerlov C; Boned A; Sieweke MH
Blood; 2005 Apr; 105(7):2707-16. PubMed ID: 15598817
[TBL] [Abstract][Full Text] [Related]
12. CLEC5A (MDL-1) is a novel PU.1 transcriptional target during myeloid differentiation.
Batliner J; Mancarelli MM; Jenal M; Reddy VA; Fey MF; Torbett BE; Tschan MP
Mol Immunol; 2011 Jan; 48(4):714-9. PubMed ID: 21094529
[TBL] [Abstract][Full Text] [Related]
13. PU.1 but not ets-2 is essential for macrophage development from embryonic stem cells.
Henkel GW; McKercher SR; Yamamoto H; Anderson KL; Oshima RG; Maki RA
Blood; 1996 Oct; 88(8):2917-26. PubMed ID: 8874188
[TBL] [Abstract][Full Text] [Related]
14. Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy.
Gu X; Hu Z; Ebrahem Q; Crabb JS; Mahfouz RZ; Radivoyevitch T; Crabb JW; Saunthararajah Y
J Biol Chem; 2014 May; 289(21):14881-95. PubMed ID: 24695740
[TBL] [Abstract][Full Text] [Related]
15. 5-azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity.
Curik N; Burda P; Vargova K; Pospisil V; Belickova M; Vlckova P; Savvulidi F; Necas E; Hajkova H; Haskovec C; Cermak J; Krivjanska M; Trneny M; Laslo P; Jonasova A; Stopka T
Leukemia; 2012 Aug; 26(8):1804-11. PubMed ID: 22343522
[TBL] [Abstract][Full Text] [Related]
16. In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression.
Kihara-Negishi F; Yamamoto H; Suzuki M; Yamada T; Sakurai T; Tamura T; Oikawa T
Oncogene; 2001 Sep; 20(42):6039-47. PubMed ID: 11593411
[TBL] [Abstract][Full Text] [Related]
17. A composite C/EBP binding site is essential for the activity of the promoter of the IL-3/IL-5/granulocyte-macrophage colony-stimulating factor receptor beta c gene.
van Dijk TB; Baltus B; Raaijmakers JA; Lammers JW; Koenderman L; de Groot RP
J Immunol; 1999 Sep; 163(5):2674-80. PubMed ID: 10453008
[TBL] [Abstract][Full Text] [Related]
18. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A
J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049
[TBL] [Abstract][Full Text] [Related]
19. Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages.
Marecki S; Atchison ML; Fenton MJ
J Immunol; 1999 Sep; 163(5):2713-22. PubMed ID: 10453013
[TBL] [Abstract][Full Text] [Related]
20. Direct interaction of PU.1 with oncogenic transcription factors reduces its serine phosphorylation and promoter binding.
Seshire A; Rößiger T; Frech M; Beez S; Hagemeyer H; Puccetti E
Leukemia; 2012 Jun; 26(6):1338-47. PubMed ID: 22105598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
